{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T11:48:31Z","timestamp":1782906511325,"version":"3.54.5"},"reference-count":52,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Simcyp Ltd"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.xphs.2017.05.003","type":"journal-article","created":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T16:47:59Z","timestamp":1494262079000},"page":"2826-2838","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["The Constraints, Construction, and Verification of a Strain-Specific Physiologically Based Pharmacokinetic Rat Model"],"prefix":"10.1016","volume":"106","author":[{"given":"Helen","family":"Musther","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Harwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiansong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Rostami-Hodjegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Jamei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.xphs.2017.05.003_bib1","first-page":"509","article-title":"Physiologically based pharmacokinetic (PBPK) modeling and simulation: applications in lead optimization","volume":"12","author":"Peters","year":"2009","journal-title":"Curr Opin Drug Discov Devel"},{"issue":"10","key":"10.1016\/j.xphs.2017.05.003_bib2","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1124\/dmd.107.015644","article-title":"Prediction of human pharmacokinetics using physiologically based modeling: a retrospective analysis of 26 clinically tested drugs","volume":"35","author":"De Buck","year":"2007","journal-title":"Drug Metab Dispos"},{"issue":"8","key":"10.1016\/j.xphs.2017.05.003_bib3","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1124\/dmd.110.037234","article-title":"Preclinical and clinical pharmacokinetics of PF-02413873, a nonsteroidal progesterone receptor antagonist","volume":"39","author":"Bungay","year":"2011","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.xphs.2017.05.003_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00498250701668600","article-title":"Quantitative analysis of aryl hydrocarbon receptor activation using fluorescence-based cell imaging\u2014a high-throughput mechanism-based assay for drug discovery","volume":"38","author":"Garside","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1016\/j.xphs.2017.05.003_bib5","series-title":"Guidance for Industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers","year":"2015"},{"key":"10.1016\/j.xphs.2017.05.003_bib6","series-title":"ICH Topic M3. (R2). Non-clinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals","year":"2009"},{"key":"10.1016\/j.xphs.2017.05.003_bib7","series-title":"Guidance for Industry: Safety Testing of Drug Metabolites","year":"2008"},{"issue":"8","key":"10.1016\/j.xphs.2017.05.003_bib8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3109\/00498254.2011.562330","article-title":"From definition to implementation: a cross-industry perspective of past, current and future MIST strategies","volume":"41","author":"Nedderman","year":"2011","journal-title":"Xenobiotica"},{"issue":"10","key":"10.1016\/j.xphs.2017.05.003_bib9","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1021\/tx900213j","article-title":"A\u00a0holistic strategy for characterizing the safety of metabolites through drug discovery and development","volume":"22","author":"Walker","year":"2009","journal-title":"Chem Res Toxicol"},{"issue":"1","key":"10.1016\/j.xphs.2017.05.003_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2133\/dmpk.24.53","volume":"24","author":"Jamei","year":"2009","journal-title":"Drug Metab Pharmacokinet"},{"issue":"2","key":"10.1016\/j.xphs.2017.05.003_bib11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1517\/17425250802691074","article-title":"The Simcyp population-based ADME simulator","volume":"5","author":"Jamei","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"10.1016\/j.xphs.2017.05.003_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10928-007-9073-1","article-title":"Early identification of drug-induced impairment of gastric emptying through physiologically based pharmacokinetic (PBPK) simulation of plasma concentration-time profiles in rat","volume":"35","author":"Peters","year":"2008","journal-title":"J\u00a0Pharmacokinet Pharmacodyn"},{"issue":"11","key":"10.1016\/j.xphs.2017.05.003_bib13","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1002\/jps.23266","article-title":"Development of a physiologically based pharmacokinetic model for the rat central nervous system and determination of an in\u00a0vitro-in\u00a0vivo scaling methodology for the blood-brain barrier permeability of two transporter substrates, morphine and oxycodone","volume":"101","author":"Ball","year":"2012","journal-title":"J\u00a0Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2017.05.003_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/cpt.37","article-title":"Physiologically based pharmacokinetic modeling in drug discovery and development: a pharmaceutical industry perspective","volume":"97","author":"Jones","year":"2015","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.xphs.2017.05.003_bib15","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/clpt.2010.298","article-title":"Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review","volume":"89","author":"Zhao","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.xphs.2017.05.003_bib16","series-title":"Guideline on the Qualification and Reporting of\u00a0Physiologically Based Pharmacokinetic (PBPK) Modelling and Simulation","year":"2016"},{"issue":"2","key":"10.1016\/j.xphs.2017.05.003_bib17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1208\/s12248-009-9099-y","article-title":"Population-based mechanistic prediction of oral drug absorption","volume":"11","author":"Jamei","year":"2009","journal-title":"AAPS J"},{"issue":"7","key":"10.1016\/j.xphs.2017.05.003_bib18","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1018943613122","article-title":"Physiological parameters in laboratory animals and humans","volume":"10","author":"Davies","year":"1993","journal-title":"Pharm Res"},{"issue":"8","key":"10.1016\/j.xphs.2017.05.003_bib19","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s11095-006-9041-2","article-title":"Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model","volume":"23","author":"Cao","year":"2006","journal-title":"Pharm Res"},{"issue":"7","key":"10.1016\/j.xphs.2017.05.003_bib20","doi-asserted-by":"crossref","first-page":"676","DOI":"10.2174\/138920007782109733","article-title":"Prediction of intestinal first-pass drug metabolism","volume":"8","author":"Yang","year":"2007","journal-title":"Curr Drug Metab"},{"issue":"1","key":"10.1016\/j.xphs.2017.05.003_bib21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jps.10005","article-title":"Prediction of pharmacokinetics prior to in\u00a0vivo studies. 1. Mechanism-based prediction of volume of distribution","volume":"91","author":"Poulin","year":"2002","journal-title":"J\u00a0Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2017.05.003_bib22","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1002\/jps.20073","article-title":"Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination","volume":"93","author":"Berezhkovskiy","year":"2004","journal-title":"J\u00a0Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2017.05.003_bib23","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/jps.20323","article-title":"Tissue distribution of basic drugs: accounting for enantiomeric, compound and regional differences amongst beta-blocking drugs in rat","volume":"94","author":"Rodgers","year":"2005","journal-title":"J\u00a0Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2017.05.003_bib24","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/jps.20502","article-title":"Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions","volume":"95","author":"Rodgers","year":"2006","journal-title":"J\u00a0Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2017.05.003_bib25","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1007\/s11095-006-9210-3","article-title":"Mechanistic approaches to volume of distribution predictions: understanding the processes","volume":"24","author":"Rodgers","year":"2007","journal-title":"Pharm Res"},{"issue":"5","key":"10.1016\/j.xphs.2017.05.003_bib26","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ejps.2009.12.002","volume":"39","author":"Rowland Yeo","year":"2010","journal-title":"Eur J Pharm Sci"},{"issue":"8","key":"10.1016\/j.xphs.2017.05.003_bib27","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3109\/00498254.2011.560294","article-title":"Sources of interindividual variability in IVIVE of clearance: an investigation into the prediction of benzodiazepine clearance using a mechanistic population-based pharmacokinetic model","volume":"41","author":"Cubitt","year":"2011","journal-title":"Xenobiotica"},{"issue":"6","key":"10.1016\/j.xphs.2017.05.003_bib28","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/jps.2600730631","article-title":"In\u00a0vitro and in\u00a0vivo assessment of hepatic and extrahepatic metabolism of diazepam in the rat","volume":"73","author":"Igari","year":"1984","journal-title":"J\u00a0Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2017.05.003_bib29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3109\/00498254.2010.538090","article-title":"Pharmacokinetics and first-pass elimination of metoprolol in rats: contribution of intestinal first-pass extraction to low bioavailability of metoprolol","volume":"41","author":"Yoon","year":"2011","journal-title":"Xenobiotica"},{"issue":"3","key":"10.1016\/j.xphs.2017.05.003_bib30","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1124\/jpet.102.035972","article-title":"In\u00a0vitro, pharmacokinetic, and pharmacodynamic interactions of ketoconazole and midazolam in the rat","volume":"302","author":"Kotegawa","year":"2002","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.xphs.2017.05.003_bib31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0005-2760(67)90152-X","article-title":"Lipid composition of erythrocytes in various mammalian species","volume":"144","author":"Nelson","year":"1967","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.1016\/j.xphs.2017.05.003_bib32","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/bdd.2510160502","article-title":"Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals","volume":"16","author":"Kararli","year":"1995","journal-title":"Biopharm Drug Dispos"},{"issue":"6","key":"10.1016\/j.xphs.2017.05.003_bib33","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-2036.1989.tb00254.x","article-title":"pH-profile and regional transit times of the normal gut measured by a radiotelemetry device","volume":"3","author":"Fallingborg","year":"1989","journal-title":"Aliment Pharmacol Ther"},{"issue":"44","key":"10.1016\/j.xphs.2017.05.003_bib34","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.3748\/wjg.v12.i44.7149","article-title":"Effect of Kaiyu Qingwei Jianji on the morphometry and residual strain distribution of small intestine in experimental diabetic rats","volume":"12","author":"Sha","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.xphs.2017.05.003_bib35","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1023\/A:1023879001294","article-title":"Prediction of in\u00a0vivo tissue distribution from in\u00a0vitro data. 2. Influence of albumin diffusion from tissue pieces during an in\u00a0vitro incubation on estimated tissue-to-unbound plasma partition coefficients (Kpu)","volume":"20","author":"Ballard","year":"2003","journal-title":"Pharm Res"},{"issue":"5","key":"10.1016\/j.xphs.2017.05.003_bib36","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF02353860","article-title":"Physiologically based pharmacokinetic study on a cyclosporin derivative, SDZ IMM 125","volume":"22","author":"Kawai","year":"1994","journal-title":"J\u00a0Pharmacokinet Biopharm"},{"issue":"1","key":"10.1016\/j.xphs.2017.05.003_bib37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/138920007779315053","article-title":"Scaling factors for the extrapolation of in\u00a0vivo metabolic drug clearance from in\u00a0vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver","volume":"8","author":"Barter","year":"2007","journal-title":"Curr Drug Metab"},{"issue":"6","key":"10.1016\/j.xphs.2017.05.003_bib38","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1124\/dmd.107.019687","article-title":"Characterization of cytochrome P450 protein expression along the entire length of the intestine of male and female rats","volume":"36","author":"Mitschke","year":"2008","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"10.1016\/j.xphs.2017.05.003_bib39","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0090-9556(25)07956-5","article-title":"Tissue distribution of 14C-diazepam and its metabolites in rats","volume":"10","author":"Igari","year":"1982","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.xphs.2017.05.003_bib40","first-page":"205","article-title":"Kinetics of distribution of substances administered to the body, I: the extravascular modes of administration","volume":"57","author":"Teorell","year":"1937","journal-title":"Arch Int Pharmacodyn Ther"},{"issue":"1","key":"10.1016\/j.xphs.2017.05.003_bib41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/15287399509532021","article-title":"An algorithm for predicting tissue: blood partition coefficients of organic chemicals from n-octanol: water partition coefficient data","volume":"46","author":"Poulin","year":"1995","journal-title":"J\u00a0Toxicol Environ Health"},{"issue":"1","key":"10.1016\/j.xphs.2017.05.003_bib42","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1520-6017(200001)89:1<16::AID-JPS3>3.0.CO;2-E","article-title":"A\u00a0priori prediction of tissue:plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery","volume":"89","author":"Poulin","year":"2000","journal-title":"J\u00a0Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2017.05.003_bib43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF01062191","article-title":"Physiologic modeling of cyclosporin kinetics in rat and man","volume":"19","author":"Bernareggi","year":"1991","journal-title":"J\u00a0Pharmacokinet Biopharm"},{"issue":"9","key":"10.1016\/j.xphs.2017.05.003_bib44","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1124\/dmd.104.000125","article-title":"Substrate depletion approach for determining in\u00a0vitro metabolic clearance: time dependencies in hepatocyte and microsomal incubations","volume":"32","author":"Jones","year":"2004","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"10.1016\/j.xphs.2017.05.003_bib45","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3109\/00498259509046662","article-title":"Kinetics of diazepam metabolism in rat hepatic microsomes and hepatocytes and their use in predicting in\u00a0vivo hepatic clearance","volume":"25","author":"Zomorodi","year":"1995","journal-title":"Xenobiotica"},{"issue":"10","key":"10.1016\/j.xphs.2017.05.003_bib46","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1002\/jps.22552","article-title":"PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance","volume":"100","author":"Ring","year":"2011","journal-title":"J\u00a0Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2017.05.003_bib47","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3109\/00498254.2011.627477","article-title":"Application of PBPK modelling in drug discovery and development at Pfizer","volume":"42","author":"Jones","year":"2012","journal-title":"Xenobiotica"},{"issue":"1","key":"10.1016\/j.xphs.2017.05.003_bib48","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1124\/dmd.109.029629","article-title":"Prediction of V(ss) from in\u00a0vitro tissue-binding studies","volume":"38","author":"Berry","year":"2010","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"10.1016\/j.xphs.2017.05.003_bib49","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1124\/dmd.110.032227","article-title":"Contribution of rat pulmonary metabolism to the elimination of lidocaine, midazolam, and nifedipine","volume":"38","author":"Aoki","year":"2010","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.xphs.2017.05.003_bib50","doi-asserted-by":"crossref","first-page":"175","DOI":"10.14573\/altex.2011.3.175","article-title":"Can case study approaches speed implementation of the NRC report: \u201ctoxicity testing in the 21st century: a vision and a strategy?\u201d","volume":"28","author":"Andersen","year":"2011","journal-title":"ALTEX"},{"issue":"9","key":"10.1016\/j.xphs.2017.05.003_bib51","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3109\/10408444.2011.575765","article-title":"Animal models of idiosyncratic drug-induced liver injury\u2014current status","volume":"41","author":"Roth","year":"2011","journal-title":"Crit Rev Toxicol"},{"key":"10.1016\/j.xphs.2017.05.003_bib52","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-pharmtox-010510-100540","article-title":"Physiologically-based pharmacokinetics in drug development and regulatory science","volume":"51","author":"Rowland","year":"2011","journal-title":"Annu Rev Pharmacol Toxicol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354917303520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354917303520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T09:03:54Z","timestamp":1750237434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354917303520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0022354917303520"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2017.05.003","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Constraints, Construction, and Verification of a Strain-Specific Physiologically Based Pharmacokinetic Rat Model","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2017.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}